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Background
The RV144 trial has rekindled interest in defining the epi-
topes responsible for the neutralization of CRF01_AE
(clade E) viruses. In this study we used a novel method,
swarm analysis, to map epitopes on Thai viruses recog-
nized by broadly neutralizing (bN) antibodies in HIV+
sera. Swarm analysis relies on the swarm of closely related
quasi-species that evolve in each HIV+ individual. In these
studies we analyzed the bN activity in sera from elite neu-
tralizers (ENs) against Thai viruses.
Methods
Libraries of envelope genes were amplified from 30 Thai
subjects who became infected with HIV in the VAX003
clinical trial. 12-24 clones from each individual were tested
for sensitivity and resistance to neutralization by HIV+ EN
sera obtained in Thailand and the USA. Pairs of neutrali-
zation sensitive and resistant viruses were identified from
each individual, and the amino acids responsible for neu-
tralization sensitivity localized by mutagenesis.
Results
Novel mutations were identified that conferred neutrali-
zation sensitivity or resistance to antibodies from ENs.
Unlike previous studies with clade B viruses, the muta-
tions in clade E viruses that altered neutralization sensi-
tivity and resistance did not appear to affect the CD4
binding site or gp41. The mutations identified were
located in V1, V2, and V3 domains of gp120 and had no
effect on neutralization by bN monoclonal antibodies
such as VRC01, b12, PG9, PG16, and 2G12.
Conclusion
Clade E viruses from Thailand can be neutralized by HIV+
sera from ENs infected with clade B or clade E viruses.
The epitopes on clade E viruses recognized by bNAbs
from ENs appear to be distinct from those defined with
most of the bN monoclonal antibodies described to date.
The results suggest that antibodies to the V1 domain as
well as the V2 domain should be considered in the RV144
correlates analysis.
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